Cartrade Tech surged 10.88% to Rs 2,104.25 after the company reported a 105.59% jump in consolidated net profit to Rs 47.06 crore in Q1 FY26 as compared with Rs 22.89 crore in Q1 FY25.

The ongoing Phase I/IIa study (NCT04725331) is a multicenter, open label, dose-escalation study evaluating BT-001 as a single agent and in combination with MSD’s (Merck & Co., Inc., Rahway, NJ, USA) ...

The Resilience Exchange tackled the most pressing issues facing South African businesses today. Here are the highlights.